Modality.AI
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
149 New Montgomery St Fl 4, San Francisc...Phone Number
(415) 200-8535Website
www.modality.aiRevenue
<$5 MillionIndustry
About Modality.AI
Modality.AI, Inc. has created the first automated, clinically validated, multimodal system for assessing neurological and psychiatric states both in clinic and remotely. Their platform enhances clinical trials and research by providing better data and faster results at scale, focusing on conditions like ALS, Parkinson's, and depression, among others. The company's conversational AI system allows for real-time monitoring of patients, enabling more efficient and effective clinical trials without the need for special software. Modality collaborates with leading institutions and serves a diverse client base, from biotech startups to major pharmaceutical companies.Explore more
Modality.AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Modality.AI
Compare insights from companies similar to Modality.AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Modality.AI Tech Stack
A closer look at the technologies used by Modality.AI
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Modality.AI
Sign Up For FreeTo access detailed company insights
Modality.AI, Inc. has created the first automated, clinically validated, multimodal system for assessing neurological and psychiatric states both in clinic and remotely. Their platform enhances clinical trials and research by providing better data and faster results at scale, focusing on conditions like ALS, Parkinson's, and depression, among other... Read More
